1st Quarter - Report

RUBICON ADVISORS, LLC for AQUESTIVE THERAPEUTICS, INC

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act

LobbyistCovered position, as disclosed
WILLIAM BURKE —

Contacted: Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.